Research Study to Compare a New Medicine "Fast-acting Insulin Aspart" to Another Medicine "Insulin Aspart" in Chinese People With Diabetes

Clinical trial NCT04588259 · COMPLETED

Trial details

NCT number: NCT04588259
Sponsor: Novo Nordisk A/S
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Diabetes Mellitus, Type 1 Diabetes Mellitus, Type 2

Start date: 2020-10-09
Primary completion: 2022-07-05
Enrollment: 331

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.